Role of Thrombin in Angiogenesis and Tumor Progression

Clinical, laboratory, histopathological, and pharmacological evidence support the notion that the coagulation system, which is activated in most cancer patients, plays an important role in tumor biology. Our laboratory has provided evidence that thrombin activates angiogenesis, a process which is essential in tumor growth and metastasis. This event is independent of fibrin formation. At the cellular level many actions of thrombin can contribute to activation of angiogenesis: (1) Thrombin decreases the ability of endothelial cells to attach to basement membrane proteins. (2) Thrombin greatly potentiates vascular endothelial growth factor- (VEGF-) induced endothelial cell proliferation. This potentiation is accompanied by up-regulation of the expression of VEGF receptors (kinase insert domain-containing receptor [KDR] and fms-like tyrosine kinase [Flt-1]). (3) Thrombin increases the mRNA and protein levels of α_vβ₃ integrin and serves as a ligand to this receptor. Furthermore, thrombin increases the secretion of VEGF and enhances the expression and protein synthesis of matrix metalloprotease-9 and α_vβ₃ integrin in human prostate cancer PC-3 cells. These results could explain the angiogenic and tumor-promoting effect of thrombin and provide the basis for development of thrombin receptor mimetics or antagonists for therapeutic application.

Thrombin - angiogenesis - tumor - VEGF - integrin

REFERENCES

• 1 Dano K, Andreasen P A, Grondahl-Hansen J et al.. Plasminogen activators, tissue degradation, and cancer [review].  Adv Cancer Res. 1985;  44 139-266
• 2 Nash G F, Walsh D C, Kakkar A K. The role of the coagulation system in tumor angiogenesis.  Lancet Oncol. 2001;  2 608-613
• 3 Rickles F R, Edwards R L. Activation of blood coagulation in cancer: Trousseau's syndrome revisited.  Blood. 1983;  62 14-31
• 4 Del Rosso M, Fibbi G, Pucci M et al.. Multiple pathways of cell invasion are regulated by multiple families of serine proteases.  Clin Exp Metastasis. 2002;  19 193-207
• 5 Martin D MA, Boys C WG, Ruf W. Tissue factor: molecular recognition and cofactor function.  FASEB J. 1995;  9 852-859
• 6 Hillen H F. Thrombosis in cancer patients.  Ann Oncol. 2000;  11 273-276
• 7 Tsopanoglou N E, Pipili-Synetos E, Maragoudakis M E. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation.  Am J Physiol. 1993;  264 C1302-C1307
• 8 Folkman J. Tumour angiogenesis.  Adv Cancer Res. 1985;  43 175-203
• 9 Wojtukiewicz M Z, Tang D G, Benjosef E et al.. Solid tumor cells express functional tethered ligand thrombin receptor.  Cancer Res. 1995;  55 698-704
• 10 Even-Ram S, Uziely B, Cohen P et al.. Thrombin receptor overexpression in malignant and physiological invasion processes.  Nat Med. 1998;  4 909-914
• 11 Zacharski L R, Memoli V A, Morain W D et al.. Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding.  Thromb Haemost. 1995;  73 793-797
• 12 Mohle R, Green D, Moore M A et al.. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets.  Proc Natl Acad Sci USA. 1997;  94 663-669
• 13 Tsopanoglou N E, Maragoudakis M E. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by upregulation of its receptors.  J Biol Chem. 1999;  274 23969-23976
• 14 Klepfish B, Greco M A, Karpatkin S. Thrombin stimulates melanoma tumor cell binding to endothelial cells and subendothelial matrix.  Int J Cancer. 1993;  53 978-982
• 15 Wojtukiewicz M Z, Tang D G, Ciarelli J J et al.. Thrombin increases the metastatic potential of tumor cells.  Int J Cancer. 1993;  54 793-806
• 16 Nierodzik M L, Klepfish B, Karpatkin S. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willenbrand factor on tumor adhesion in vitro and metastasis in vivo.  Thromb Haemost. 1995;  74 282-290
• 17 Dardik R, Savion N, Kaufman Y et al.. Thrombin promotes platelets-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoprotein P-selectin and GPIIb-IIIa.  Br J Cancer. 1998;  77 2069-2075
• 18 Haralambopoulos G C, Grant D S, Klienman H K, Maragoudakis M E. Thrombin promotes endothelial cell alignment in matrigel in vitro and angiogenesis in vivo.  Am J Physiol. 1997;  273 C239-C242
• 19 Dimitropoulou C, Malkush W, Fait E, Maragoudakis M E, Konerding M A. The vascular architecture of the chick chorioallantoic membrane: sequential quantitative evaluation using corrosion casting.  Angiogenesis. 1998;  2 255-263
• 20 Maragoudakis M E, Tsopanoglou N E, Sakkoula E, Pipili-Synetos E. On the mechanism of promotion of angiogenesis by thrombin [abstract].  FASEB J. 1995;  9 A587
• 21 Herbert J M, Dupuy E, Laplace M C et al.. Thrombin induces endothelial cell growth via both proteolytic and non-proteolytic pathways.  Biochem J. 1994;  303 227-231
• 22 McNamara C A, Sarembock I J, Gimple L W et al.. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.  J Clin Invest. 1993;  91 94-98
• 23 Macfarlane S R, Seatter M J, Kanke T et al.. Proteinase-activated receptors.  Pharmacol Rev. 2001;  53 245-282
• 24 Tsopanoglou N E, Maragoudakis M E. On the mechanism of thrombin-induced angiogenesis: inhibition of attachment of endothelial cells on basement membrane components.  Angiogenesis. 1998;  1 192-200
• 25 Maragoudakis M E, Kraniti N, Giannopoulou E et al.. Modulation of angiogenesis and progelatinase A by thrombin receptor mimetic and antagonists.  Endothelium. 2001;  8 195-205
• 26 Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease.  Nat Med. 1995;  1 27-31
• 27 Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor.  Endocr Rev. 1997;  18 4-25
• 28 Eliceiri B P, Cheresh D A. Adhesion events in angiogenesis.  Curr Opin Cell Biol. 2001;  13 563-568
• 29 Felding-Habermann B, Mueller B M, Romerdahl C A, Cheresh D A. Involvement of integrin α_v gene expression in human melanoma tumorigenicity.  J Clin Invest. 1992;  89 2018-2022
• 30 Enenstein J, Kramer R H. Confocal microscopic analysis of integrin expression on the microvasculature and its sprouts in the neonatal foreskin.  J Invest Dermatol. 1994;  103 381-386
• 31 Brooks P C, Clark R A, Cheresh D A. Requirement of vascular integrin α_vβ₃ for angiogenesis.  Science. 1994;  264 569-571
• 32 Bader B L, Rayburn H, Crowley D, Hynes R O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins.  Cell. 1998;  95 507-519
• 33 Kumar C C, Malkowski M, Yin Z et al.. Inhibition of angiogenesis and tumor growth by SCH221153, and dual α_vβ₃ and α_vβ₅ integrin receptor antagonist.  Cancer Res. 2001;  61 2232-2238
• 34 Storgard C M, Stupack D G, Jonczyk A. Decreased angiogenesis and arthritis disease in rabbit treated with an α_vβ₃ antagonist.  J Clin Invest. 1999;  103 47-54
• 35 Tsopanoglou N E, Andriopoulou P, Maragoudakis M E. On the mechanism of thrombin-induced angiogenesis: involvement of α_vβ₃ integrin.  Am J Physiol. 2002;  283 C1501-C1510
• 36 Conforti G C, Dominguez-Jimenez B, Zanetti M A et al.. Human endothelial cells express integrin receptors on the luminal aspect of their membrane.  Blood. 1992;  80 437-446
• 37 Ruoslahti E. RGD and other recognition sequences for integrins.  Annu Rev Cell Dev Biol. 1996;  12 697-715
• 38 Giancotti F G, Ruoslahti E. Integrin signaling.  Science. 1999;  285 1028-1032
• 39 Brooks P C, Silletti S, von Schalscha T L, Friedlander M, Cheresh D A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.  Cell. 1998;  92 391-400
• 40 Zucker S, Conner C, Massimo B et al.. Thrombin induces the activation of progelatinase A in vascular endothelial cells.  J Biol Chem. 1995;  270 23730-23738
• 41 Johnsen M, Lund L R, Romer J, Amholt K, Dano K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation.  Curr Opin Cell Biol. 1998;  10 667-671
• 42 Zucker S, Mirza H, Conner C E et al.. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation.  Int J Cancer. 1998;  75 780-786
• 43 Nierodzik M L, Kajumo F, Karpatkin S. Effects of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo.  Cancer Res. 1992;  52 3267-3272
• 44 Even-Ram S C, Maoz M, Pokroy E et al.. Tumor invasion is promoted by activation of protease activated receptor-1 in cooperation with the α_vβ₅ integrin.  J Biol Chem. 2001;  276 10952-10962
• 45 Bar-Shavit R, Gridley G, Vlodavsky I. Binding of thrombin to subendothelial extracellular matrix: protection and expression of functional properties.  J Clin Invest. 1989;  84 1096-1104